Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renaissance Nutraceuticals was a development-stage pharmaceutical and consumer health company that specialized in over-the-counter (OTC) homeopathic products and niche pharmaceuticals. The company is historically notable for its 'Enforma' brand and its subsequent acquisition in 2007 by Nu Pharmas, Inc., which later rebranded as Lakewood-Amedex. This acquisition facilitated the transition of the company's leadership and assets into the biotechnology sector, focusing on anti-infectives and RNA-based therapeutics. Today, the legacy of Renaissance Nutraceuticals is integrated into Lakewood-Amedex's broader portfolio of antimicrobial and antiviral programs. The company's history reflects a strategic shift from consumer-oriented health products to high-tech biopharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renaissance Nutraceuticals.